Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor &#945; Ratio.

Laux, Julian; Martorelli, Mariella; Späth, Nadja; Maier, Florian; Burnet, Michael; Laufer, Stefan A

Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α Ratio.

Laux, Julian; Martorelli, Mariella; Späth, Nadja; Maier, Florian; Burnet, Michael; Laufer, Stefan A.

Affiliation

Laux J; Synovo GmbH, Paul-Ehrlich-Straße 15, 72076 Tübingen, DE, Germany.
Martorelli M; Department of Pharmaceutical/Medicinal Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany.
Späth N; Synovo GmbH, Paul-Ehrlich-Straße 15, 72076 Tübingen, DE, Germany.
Maier F; Department of Pharmaceutical/Medicinal Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, DE, Germany.
Burnet M; Synovo GmbH, Paul-Ehrlich-Straße 15, 72076 Tübingen, DE, Germany.
Laufer SA; Synovo GmbH, Paul-Ehrlich-Straße 15, 72076 Tübingen, DE, Germany.

ACS Pharmacol Transl Sci ; 6(6): 892-906, 2023 Jun 09.

Article in En | MEDLINE | ID: mdl-37325444

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ACS Pharmacol Transl Sci Year: 2023 Document type: Article Affiliation country: Germany Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google